Cargando…

Cell-Free DNA From Metastatic Pancreatic Neuroendocrine Tumor Patients Contains Tumor-Specific Mutations and Copy Number Variations

Background: Detection of tumor-specific alterations in cell-free DNA (cfDNA) has proven valuable as a liquid biopsy for several types of cancer. So far, use of cfDNA remains unexplored for pancreatic neuroendocrine tumor (PNET) patients. Methods: From 10 PNET patients, fresh frozen tumor tissue, buf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boons, Gitta, Vandamme, Timon, Peeters, Marc, Beyens, Matthias, Driessen, Ann, Janssens, Katrien, Zwaenepoel, Karen, Roeyen, Geert, Van Camp, Guy, Op de Beeck, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221938/ https://www.ncbi.nlm.nih.gov/pubmed/30443491 http://dx.doi.org/10.3389/fonc.2018.00467

Ejemplares similares

Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up
por: Boons, Gitta, et al.
Publicado: (2022)

PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis
por: Boons, Gitta, et al.
Publicado: (2020)

Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors
por: Vandamme, Timon, et al.
Publicado: (2016)

Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma
por: Hylebos, Marieke, et al.
Publicado: (2017)

pyAmpli: an amplicon-based variant filter pipeline for targeted resequencing data
por: Beyens, Matthias, et al.
Publicado: (2017)

Genome‐wide DNA methylation profiling and identification of potential pan‐cancer and tumor‐specific biomarkers
por: Ibrahim, Joe, et al.
Publicado: (2022)

The Gasdermin E Gene Has Potential as a Pan-Cancer Biomarker, While Discriminating between Different Tumor Types
por: Ibrahim, Joe, et al.
Publicado: (2019)

Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer
por: Ibrahim, Joe, et al.
Publicado: (2019)

Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer
por: Croes, Lieselot, et al.
Publicado: (2018)

A Belgian Population-Based Study Reveals Subgroups of Right-sided Colorectal Cancer with a Better Prognosis Compared to Left-sided Cancer
por: Janssens, Katleen, et al.
Publicado: (2023)

Epigenome-wide methylation analysis of colorectal carcinoma, adenoma and normal tissue reveals novel biomarkers addressing unmet clinical needs
por: Janssens, Katleen, et al.
Publicado: (2023)

Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine
por: Simbolo, Michele, et al.
Publicado: (2018)

Determination of the Potential Tumor-Suppressive Effects of Gsdme in a Chemically Induced and in a Genetically Modified Intestinal Cancer Mouse Model
por: Croes, Lieselot, et al.
Publicado: (2019)

Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization
por: Hashemi, Jamileh, et al.
Publicado: (2013)

Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Role of DFNA5 in hearing loss and cancer – a comment on Rakusic et al
por: Croes, Lieselot, et al.
Publicado: (2015)

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer
por: Deben, Christophe, et al.
Publicado: (2015)

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)?
por: Hiddinga, Birgitta, et al.
Publicado: (2022)

Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy—The Role of Liquid Biopsy in Unraveling the Puzzle
por: Augustus, Elien, et al.
Publicado: (2021)

DFNA5 promoter methylation a marker for breast tumorigenesis
por: Croes, Lieselot, et al.
Publicado: (2017)

Author Correction: Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Correlation Between Apparent Diffusion Coefficient Value on MRI and Histopathologic WHO Grades of Neuroendocrine Tumors
por: Mebis, Wouter, et al.
Publicado: (2020)

The splicing mutant of the human tumor suppressor protein DFNA5 induces programmed cell death when expressed in the yeast Saccharomyces cerevisiae
por: Van Rossom, Sofie, et al.
Publicado: (2012)

Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer
por: Domen, Andreas, et al.
Publicado: (2021)

Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies
por: Boeckx, N., et al.
Publicado: (2017)

Analysis of gene copy number changes in tumor phylogenetics
por: Zhou, Jun, et al.
Publicado: (2016)

The deafness gene DFNA5 induces programmed cell death through mitochondria and MAPK-related pathways
por: Van Rossom, Sofie, et al.
Publicado: (2015)

Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity
por: Rasmussen, Markus, et al.
Publicado: (2011)

Breast tumor copy number aberration phenotypes and genomic instability
por: Fridlyand, Jane, et al.
Publicado: (2006)

The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer
por: de Abreu, Ana Regina, et al.
Publicado: (2023)

The art of obtaining a high yield of cell-free DNA from urine
por: Augustus, Elien, et al.
Publicado: (2020)

Inferring models of multiscale copy number evolution for single-tumor phylogenetics
por: Chowdhury, Salim Akhter, et al.
Publicado: (2015)

Meta-mining of copy number profiles of high-risk neuroblastoma tumors
por: Depuydt, Pauline, et al.
Publicado: (2018)

Clonality analysis of pulmonary tumors by genome-wide copy number profiling
por: Vincenten, Julien P. L., et al.
Publicado: (2019)

Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies
por: Debattista, Jessica, et al.
Publicado: (2023)

Neuroendocrine Carcinoma of the Kidney and Bladder with Loss of Heterozygosity and Changes in Chromosome 3 Copy Number
por: Okada, Atsushi, et al.
Publicado: (2015)

Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes
por: Gao, Ruli, et al.
Publicado: (2021)

P-230 Is stereotactic microwave ablation of resectable colorectal liver metastasis an alternative for liver resection in the Covid-19 pandemic?
por: Chapelle, T., et al.
Publicado: (2021)

MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients
por: Deben, Christophe, et al.
Publicado: (2017)

Loss of copy of MIR1-2 increases CDK4 expression in ileal neuroendocrine tumors
por: Contractor, Tanupriya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nohe607nl154347lt11v8qqjmu